On October 17th, marijuana will officially become legal in Canada. In the upcoming weeks, cannabis stocks are likely to lead the entire stock market in percentage gains. NIA is 1,000% confident that Pure Global Cannabis (TSXV: PURE) will become one of the largest gaining cannabis plays in the entire market!
PURE is rapidly approaching the grand opening later this year of their cannabis cultivationfacility near the Toronto Pearson International Airport. Today, PURE announced that its wholly-owned PureSinse subsidiary has received approval for an amendment to its licence from Health Canada under the Access to Cannabis for Medical Purposes Regulations (ACMPR), to include the possession of cannabis oil, resin, and relevant activities. PURE is now officially allowed to source bulk psychoactive and non-psychoactive cannabis oils along with resins from national and international licensed producers that meet PURE’s high quality standards.
PURE anticipates that PureSinse will be granted a cannabis oils production and processing licence by year-end 2018 and subsequent oils sales licence in early 2019. Upon final licensing approval, PureSinse will have the ability to sell cannabis oil products to registered patients under the ACMPR, for adult legal use under the Cannabis Act, and for export purposes, along with its current dried medical cannabis products. PURE intends to begin generating revenue from oils in the upcoming quarters, while investing big into the R&D of innovative new cannabis oils-based products.
PURE has successfully completed the Phase 1 build-out of its multi-ponic vertical cultivation facility near the Toronto Pearson International Airport. PURE has commenced its Phase 2 and Phase 3 congruent build-outs, which are expected to be complete in 4Q 2018 and 1Q 2019, respectively. Phase 2 will have 18,000 sq ft. of proprietary multi-ponic vertical production with an expected production capacity of 4,000 kg per annum. Phase 3 will total 41,000 sq ft. of proprietary multi-ponic vertical cultivation with an expected total production capacity of 8,000 kg per annum.
PURE is positioning itself to be a dominant player in the cannabis pharma, health & wellness, and consumer goods sectors by committing itself to creating unique cannabinoid-baseddelivery systems and formulations with sustainable packaging. PURE will soon begin sellingdried flower and cannabis oils, followed by capsules, sublingual sprays, edibles, vape pens, and ultimately a full range of premium quality CBD and cannabis-based consumer goods for medical and adult-legal sales. PURE is also on track to obtain EU Good Manufacturing Practice (GMP) and ISO certifications in early 2019 for expanding its sales to international markets.
PURE is well-positioned to become one of the first major international cannabis companies.PURE has just acquired a 60% interest in Avicanna’s Colombian subsidiary Sativa Nativa S.A.S. with an option to increase its ownership to 75%. Sativa Nativa has been issued a licensefor the cultivation of psychoactive cannabis and a license for the manufacture of cannabisderivatives by the Colombian Ministry of Justice and Ministry of Health. Sativa Nativa plans to build a 1 million square foot state-of-the-art greenhouse in Santa Marta, Colombia with advanced technologies and automation to produce several fold greater than traditional methods.Avicanna already has joint ventures with Grupo Daabon, the largest organic agricultural company in the world, along with admission into Johnson & Johnson Innovation’s JLABS life sciences incubator in Toronto, Canada.